Shiri Cooper

Shiri Cooper

Auto-generated profile, based on publicly available information

Shiri Cooper

Pediatrics Department B Schneider Children's Medical Center of Israel Petach Tikva Israel

Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
10 June 2022 in Journal of Pediatric Gastroenterology and Nutrition
Verified
Journal Article
Closed access
SCShiri Cooper
Shiri Cooper
ATAna Tobar
Ana Tobar
OKOsnat Konen
Osnat Konen
NONaama Orenshtein
Naama Orenshtein
NGNesia Kropach Gilad
Nesia Kropach Gilad
OWOrith Waisbourd‐Zinman
Orith Waisbourd‐Zinman

8 September 2016 in American Journal of Neuroradiology
Verified
Journal Article
Open access
PDF file
SCS. Cooper
S. Cooper
OBO. Bar-Yosef
O. Bar-Yosef
MBM. Berkenstadt
M. Berkenstadt
CHC. Hoffmann
C. Hoffmann
RAR. Achiron
R. Achiron
EKEldad Katorza
Eldad Katorza
BACKGROUND AND PURPOSE: Periventricular pseudocysts are cystic cavities that lack the ependymal cell lining found in true cysts. The aim of this study was to characterize periventricular pseudocysts and related findings and their neurodevelopmental outcome. MATERIALS AND METHODS: This was a retrospective study of periventricular pseudocysts detected prenatally on fetal MR imaging in 26 fetuses. The fetuses were divided into group A (n = 8), which included cases with isolated periventricular pseudocysts, and group B (n = 18), which included cases of periventricular pseudocysts with additional findings. Cases were further subdivided into connatal cysts and subependymal pseudocysts. Data collected included prenatal history, MR imaging features, sonographic follow-up, and neurodevelopmental outcome. RESULTS: All cases in group A (n = 8) had a normal outcome. In group B (n = 18), 6 pregnancies were terminated and 2 had an abnormal outcome. Both cases with an abnormal outcome involved patients with subependymal pseudocysts. No significant association was found between the morphologic features on MR imaging and the neurodevelopmental outcome. CONCLUSIONS: Neurodevelopmental outcome in cases of isolated periventricular pseudocysts detected prenatally appears to be normal. A detailed evaluation should be performed to rule out additional brain findings, chromosomal aberration, and fetal malformation. This evaluation should include the following: maternal TORCH status, detailed fetal sonographic anatomic evaluation, fetal echocardiogram, fetal brain MR imaging, amniocentesis and karyotyping/comparative genomic hybridization, and genetic counseling. Additional findings on MR imaging, including mild-to-moderate dilated ventricles, asymmetric ventricles, or T2 hyperintense signal in the white matter without other findings or major fetal abnormality, appear to be benign. Connatal cysts appear to be benign.

16 August 2017 in The Journal of Maternal-Fetal & Neonatal Medicine
Verified
Journal Article
Closed access
SCShiri Cooper
Shiri Cooper
EKEldad Katorza
Eldad Katorza
MBMichal Berkenstadt
Michal Berkenstadt
CHChen Hoffmann
Chen Hoffmann
RAReuven Achiron
Reuven Achiron
OBOmer Bar-Yosef
Omer Bar-Yosef
The purpose of this study is to describe the morphological characteristics of fetal MRIs and outcome of prenatally-detected abnormal width of the CSP (cavum septum pellucidum). A retrospective study of cases with abnormal width of the CSP demonstrated prenatally on MRI. Data collected included: prenatal history, MRI features, sonographic follow up, and neurodevelopmental outcome. Most of the cases referred (34/39) had an abnormal CSP on MRI. Thirty cases had an abnormal width: 23 had narrow CSP and seven had wide CSP. Only three out of 12 cases that were referred with US diagnosis of absent CSP were confirmed by MRI, the rest had narrow CSP. Follow up was performed in 24 out of 30 cases with an abnormal CSP width; all had normal neurodevelopment. To the best of our knowledge, this is the first study to examine the outcome in narrow and wide CSPs detected prenatally. An abnormal width of the CSP prenatally, without an associated fetal abnormality such as aneuploidy, appears to have normal outcome. MRI should be offered when an absence of the CSP is suspected on US to rule out narrow CSP, which seems to be a benign finding.

12 April 2024 in Pediatric Transplantation
Verified
Journal Article
Open access
OVOdelia Vingrovich
Odelia Vingrovich
SCShiri Cooper
Shiri Cooper
MGMichael Gurevich
Michael Gurevich
ACAenov Cohen
Aenov Cohen
YMYael Mozer‐Glassberg
Yael Mozer‐Glassberg
OWOrith Waisbourd‐Zinman
Orith Waisbourd‐Zinman
Background: Biliary strictures are a significant cause of morbidity and graft loss in pediatric liver transplant recipients. Risk factors for the development of biliary strictures are not fully established. We aimed to evaluate the incidence of biliary strictures and treatment modalities outcomes and to identify potential risk factors for occurrence.Methods: Pediatric patients who underwent liver transplantation in the single tertiary pediatric liver transplant center in Israel were evaluated. We compared demographics, presentation, laboratory results, imaging, treatment, and outcomes between patients with and without biliary stricture. Multivariate regression analyses were used to identify risk factors for biliary strictures.Results: Among 121 pediatric liver transplant patients, 65 (53.7%) were males; the median age at the time of liver transplantation was 43 (3–215) months. Fifteen patients (12.4%) had biliary strictures following transplantation. One (7%) patient with biliary stricture was treated via endoscopic retrograde cholangiopancreatography, and 12 patients (80%) underwent interventions via a percutaneous transhepatic approach. Nine of the 12 patients were treated successfully, requiring one or multiple procedures, while the remaining had surgery or laser therapy. Risk factors for the development of biliary strictures were biliary leak, acute cellular rejection, and the presence of two biliary anastomoses.Conclusions: In our cohort, the presence of two biliary anastomoses and post‐transplant complications including acute cellular rejection and early biliary leaks were associated with biliary strictures in pediatric liver transplantation recipients. Percutaneous transhepatic interventions result in good outcomes in most patients.

1 November 2025 in Diseases of the Esophagus
Verified
Journal Article
Closed access
SCShiri Cooper
Shiri Cooper
LMLuba Marderfeld
Luba Marderfeld
RSRaanan Shamir
Raanan Shamir
NZNoam Zevit
Noam Zevit
Background: Empiric elimination diets remain a cornerstone of treatment for eosinophilic esophagitis (EoE). Immunoglobulin E (IgE) mediated allergic reactions have been sparsely reported during the food reintroduction phase, raising concerns both for patients and physicians. We aimed to assess the physician reported rates of new-onset IgE mediated reactions in EoE associated elimination diets (NIMREEDs), physician awareness of NIMREEDs, and how awareness impacts physician and patient treatment selection. Methods: An international REDCap based questionnaire was distributed via interest groups, gastroenterologist server lists, and professional societies. Physicians were asked about their personal awareness and experience with NIMREEDs and how their knowledge affects physician and patient treatment decisions when contemplating elimination diets (ED) for treatment of EoE. Results: Between January and July 2023, 145 responses were included in this analysis. Of the 12,698 patients with EoE cared for in all responding centers, 4903 (38.6%) had attempted ED. NIMREEDs were reported in 43/4903 (0.88% [95% CI 0.5–1.2%]). Ninety-six (66.2%) physicians were aware of potential reactions, however only 71/96 (73.9%) discussed them with patients. Knowledge of NIMREEDs deter 17/96 (17.7%) physicians from recommending ED for EoE, and 15/71 (21.1%) of those who informed patients, reported reluctance of patients to undertake ED. Conclusion: NIMREEDs following food re-introduction in the treatment of EoE are uncommon, nevertheless they are not widely recognized by physicians. Knowledge concerning NIMREEDs may affect both patient and physician treatment decisions and preferences, as they have potential to negatively affect quality of life, emphasizing the need for increased awareness to NIMREEDs in EoE patients.

11 September 2026 in Journal of Paediatrics and Child Health
Verified
Journal Article
Closed access
PDF file
TCTal Cozacov
Tal Cozacov
SCShiri Cooper
Shiri Cooper
YVYoav Vardy
Yoav Vardy
VHVered Hoffer
Vered Hoffer
YLYoel Levinsky
Yoel Levinsky
DLDaniel Landau
Daniel Landau